Authors:
Clewell, HJ
Gentry, PR
Gearhart, JM
Covington, TR
Banton, MI
Andersen, ME
Citation: Hj. Clewell et al., Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone, TOXICOL SCI, 63(2), 2001, pp. 160-172
Authors:
DeWoskin, RS
Barone, S
Clewell, HJ
Setzer, RW
Citation: Rs. Dewoskin et al., Improving the development and use of biologically based dose response models (BBDR) in risk assessment, HUM ECOL R, 7(5), 2001, pp. 1091-1120
Citation: Bd. Beck et Hj. Clewell, Uncertainty/safety factors in health risk assessment: Opportunities for improvement, HUM ECOL R, 7(1), 2001, pp. 203-207
Authors:
Clewell, HJ
Gentry, PR
Gearhart, JM
Allen, BC
Andersen, ME
Citation: Hj. Clewell et al., Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model, SCI TOTAL E, 274(1-3), 2001, pp. 37-66
Authors:
Clewell, HJ
Gentry, PR
Covington, TR
Gearhart, JM
Citation: Hj. Clewell et al., Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment, ENVIR H PER, 108, 2000, pp. 283-305
Citation: Ha. Barton et Hj. Clewell, Evaluating noncancer effects of trichloroethylene: Dosimetry, mode of action, and risk assessment, ENVIR H PER, 108, 2000, pp. 323-334
Authors:
Clewell, HJ
Gearhart, JM
Gentry, PR
Covington, TR
VanLandingham, CB
Crump, KS
Shipp, AM
Citation: Hj. Clewell et al., Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics, RISK ANAL, 19(4), 1999, pp. 547-558
Citation: Me. Andersen et al., Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese, NEUROTOXICO, 20(2-3), 1999, pp. 161-171
Citation: Ea. Maull et Hj. Clewell, The evolution of health-risk assessment: Trichloroethylene as a case study, TOXICOLOGY IN RISK ASSESSMENT, 1999, pp. 223-233